SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032131
Filing Date
2022-11-14
Accepted
2022-11-14 16:37:06
Documents
58
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1576626
2 ex31-1.htm EX-31.1 12009
3 ex31-2.htm EX-31.2 12029
4 ex-32.htm EX-32 9094
  Complete submission text file 0001493152-22-032131.txt   6920964

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20220930.xsd EX-101.SCH 51206
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT envb-20220930_cal.xml EX-101.CAL 51546
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT envb-20220930_def.xml EX-101.DEF 214536
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20220930_lab.xml EX-101.LAB 426158
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20220930_pre.xml EX-101.PRE 317969
52 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1235233
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 221386631
SIC: 2834 Pharmaceutical Preparations